Catherine Hyams

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2021 · 1.2K citations · Full text

Veterinary Medicine, Immunology, Immunization +16

Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort

David Arnold, Fergus Hamilton, Alice Milne et al. · Thorax · 2020 · 621 citations · Full text

Health Professions, Rehabilitation Medicine, Outcomes Research +13

The<i>Streptococcus</i><i>pneumoniae</i>Capsule Inhibits Complement Activity and Neutrophil Phagocytosis by Multiple Mechanisms

Catherine Hyams, Emilie Camberlein, Jonathan Cohen et al. · Infection and Immunity · 2009 · 472 citations · Full text

Life Sciences, Immunology, Microbiology +17

Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: a prospective cohort study in Bristol, United Kingdom

Catherine Hyams, Robert Challen, Robin Marlow et al. · The Lancet Regional Health - Europe · 2022 · 172 citations · Full text

Medicine, Infectious Diseases, Clinical Epidemiology +15